Chronic Pain Clinical Trial
— ECLIPSEOfficial title:
Evaluation of a Peer Coach-Led Intervention to Improve Pain Symptoms (ECLIPSE)
| Verified date | July 2023 |
| Source | VA Office of Research and Development |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
To maximize implementation potential of pain self-management in the VA, alternative delivery methods are needed to provide Veterans with education and support needed to self-manage their pain, without requiring additional resources from healthcare teams. A novel and promising approach is a peer coaching model, in which Veterans with chronic pain who are successfully managing their pain offer information, support, and mentorship to other Veterans with pain.
| Status | Completed |
| Enrollment | 215 |
| Est. completion date | August 1, 2019 |
| Est. primary completion date | August 1, 2019 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - have musculoskeletal pain in the low back, cervical spine, or extremities (hip, knee, or shoulder) for 3 months - have at least moderate pain severity, defined by pain 5 on a 0 (no pain) to 10 (worst pain imaginable) scale - indicate willingness to engage in phone or in-person contact on a regular basis with another Veteran Exclusion Criteria: - if the electronic medical record indicates a diagnosis of a psychotic disorder (e.g., International Classification of Diseases (ICD) ICD-9 codes 295-295.9 for schizophrenia) - current substance dependence (e.g., ICD-9 codes 304-304.9) - severe medical conditions precluding participation (e.g., New York Heart Association Class III or IV heart failure, ICD-9 codes 428-428.9 ) - if the eligibility screener given to prospective participants reveals active suicidal ideation severe hearing or speech impairment - pending surgery for a musculoskeletal condition (e.g., back surgery) |
| Country | Name | City | State |
|---|---|---|---|
| United States | Richard L. Roudebush VA Medical Center, Indianapolis, IN | Indianapolis | Indiana |
| Lead Sponsor | Collaborator |
|---|---|
| VA Office of Research and Development |
United States,
Matthias MS, Bair MJ, Ofner S, Heisler M, Kukla M, McGuire AB, Adams J, Kempf C, Pierce E, Menen T, McCalley S, Johnson NL, Daggy J. Peer Support for Self-Management of Chronic Pain: the Evaluation of a Peer Coach-Led Intervention to Improve Pain Symptoms — View Citation
Matthias MS, Daggy J, Adams J, Menen T, McCalley S, Kukla M, McGuire AB, Ofner S, Pierce E, Kempf C, Heisler M, Bair MJ. Evaluation of a peer coach-led intervention to improve pain symptoms (ECLIPSE): Rationale, study design, methods, and sample character — View Citation
Matthias MS, Daggy J, Ofner S, McGuire AB, Kukla M, Bair MJ. Exploring peer coaches' outcomes: Findings from a clinical trial of patients with chronic pain. Patient Educ Couns. 2020 Jul;103(7):1366-1372. doi: 10.1016/j.pec.2020.02.007. Epub 2020 Feb 5. — View Citation
Shue SA, McGuire AB, Matthias MS. Facilitators and Barriers to Implementation of a Peer Support Intervention for Patients with Chronic Pain: A Qualitative Study. Pain Med. 2019 Jul 1;20(7):1311-1320. doi: 10.1093/pm/pny229. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Brief Pain Inventory (BPI) (Overall Pain Assessment) | The BPI was developed to assess the severity of pain and the impact of pain on daily functioning, and has been validated in primary care studies. (Range = 0-10, 0 = no pain, 10 = worst pain imaginable) | 6 months | |
| Primary | Brief Pain Inventory (BPI) (Overall Pain Assessment) | The BPI was developed to assess the severity of pain and the impact of pain on daily functioning, and has been validated in primary care studies. (Range = 0-10, 0 = no pain, 10 = worst pain imaginable) | 9 months | |
| Secondary | Pain Catastrophizing | Pain Catastrophizing Scale, a 13-item scale that assesses catastrophizing - a pain belief that has been found to be a strong predictor of poor treatment response. (Range: 0-52, higher numbers = higher catastrophizing) | 6 months | |
| Secondary | Perceived Social Support | Measures perceptions of social support.(Range: 12-84, higher numbers = higher perceptions of social support) | 6 months | |
| Secondary | Perceived Social Support | Measures perceptions of social support.(Range: 12-84, higher numbers = higher perceptions of social support) | 9 months | |
| Secondary | Self Efficacy | Adapted from the Arthritis Self Efficacy Scale (Range 0-10, higher numbers = higher self efficacy) | 6 months | |
| Secondary | Self Efficacy | Adapted from the Arthritis Self Efficacy Scale (Range 0-10, higher numbers = higher self efficacy) | 9 months | |
| Secondary | Anxiety | GAD-7 (Range 0-21, higher numbers = higher anxiety) | 6 months | |
| Secondary | Anxiety | GAD-7 (Range 0-21, higher numbers = higher anxiety) | 9 months | |
| Secondary | Depression | PHQ-8 (Range: 0-24, higher numbers = higher depression) | 6 months | |
| Secondary | Depression | PHQ-8 (Range: 0-24, higher numbers = higher depression) | 9 months | |
| Secondary | Pain Catastrophizing | Pain Catastrophizing Scale, a 13-item scale that assesses catastrophizing - a pain belief that has been found to be a strong predictor of poor treatment response. (Range: 0-52, higher numbers = higher catastrophizing) | 9 months | |
| Secondary | Patient Activation | Patient Activation Measure (Range: 0-100, higher numbers = higher activation) | 6 months | |
| Secondary | Patient Activation | Patient Activation Measure (Range: 0-100, higher numbers = higher activation) | 9 months | |
| Secondary | General Health Perceptions | SF-36 General Health Perceptions (Range: 0-100, higher numbers = higher health perceptions) | 6 months | |
| Secondary | General Health Perceptions | SF-36 General Health Perceptions (Range: 0-100, higher numbers = higher health perceptions) | 9 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
| Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
| Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
| Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
| Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
| Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
| Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
| Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
| Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
| Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
| Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
| Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
| Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
| Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
| Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
| Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
| Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
| Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
| Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|